About
Microbiome-derived metabolites as drugs
Areas of Focus
Categories
Biologics & BiopharmaceuticalMicrobiomeNJ, NY, PA
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
215
By Phase
PHASE2/PHASE3: 1PHASE1: 1
By Status
NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06863493Lead Sponsor
Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis Patients
PHASE2/PHASE3Not yet recruiting
125 participants
Started: Jun 1, 2025 · Completed: Sep 1, 2026
NCT05642182Lead Sponsor
Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques
PHASE1Recruiting
90 participants
Started: Mar 31, 2022 · Completed: Jul 31, 2025
Locations (1)
Headquarters
Jenkintown, PA, United States
Map
Loading map...